Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer.

Autor: Wells SM; Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT., Boothe D; Banner MD Anderson Cancer Center, Greeley, CO., Ager BJ; Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT., Tao R; Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT., Gilcrease GW 3rd; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT., Lloyd S; Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah, Salt Lake City, UT. Electronic address: Shane.Lloyd@hci.utah.edu.

Publikováno v: Clinical colorectal cancer [Clin Colorectal Cancer] 2020 Jun; Vol. 19 (2), pp. 91-99.e1. Date of Electronic Publication: 2020 Mar 12.

The variable impact of positive lymph nodes in cervical cancer: Implications of the new FIGO staging system.

Autor: McComas KN; University of Utah School of Medicine, Salt Lake City, UT, USA., Torgeson AM; University of Utah, Department of Radiation Oncology, Salt Lake City, UT, USA., Ager BJ; University of Utah, Department of Radiation Oncology, Salt Lake City, UT, USA., Hellekson C; University of Utah, Department of Radiation Oncology, Salt Lake City, UT, USA., Burt LM; University of Utah, Department of Radiation Oncology, Salt Lake City, UT, USA., Maurer KA; University of Utah, Department of Obstetrics & Gynecology, Salt Lake City, UT, USA., Werner TL; University of Utah, Department of Internal Medicine, Salt Lake City, UT, USA., Gaffney DK; University of Utah, Department of Radiation Oncology, Salt Lake City, UT, USA. Electronic address: david.gaffney@hci.utah.edu.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2020 Jan; Vol. 156 (1), pp. 85-92. Date of Electronic Publication: 2019 Nov 16.

The value of contrast-enhanced ultrasound in cervical cancer assessed in comparison with magnetic resonance imaging.

Autor: Ignat, Radu-Mihai¹, Fekete, Zsolt^1,2, Csutak, Csaba^1,3, Todor, Nicolae⁴, Ignat, Florin Laurentiu^1,5, Ignat, Patricia Delia^1,2, Badea, Radu⁶ radu.mihai.ignat@gmail.com

Publikováno v: Medicine & Pharmacy Reports: Clujul Medical. 2024, Vol. 97 Issue 3, p255-262. 8p.

Recurrent early stage endometrial cancer: Patterns of recurrence and results of salvage therapy.

Autor: Francis SR; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Ager BJ; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Do OA; Population Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Huang YJ; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Soisson AP; Department of Obstetrics and Gynecology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Dodson MK; Department of Obstetrics and Gynecology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Werner TL; Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Sause WT; Department of Radiation Oncology, Intermountain Medical Group, Intermountain Healthcare, Salt Lake City, UT, USA., Grant JD; Department of Radiation Oncology, Intermountain Medical Group, Intermountain Healthcare, Salt Lake City, UT, USA., Gaffney DK; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. Electronic address: david.gaffney@hci.utah.edu.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2019 Jul; Vol. 154 (1), pp. 38-44. Date of Electronic Publication: 2019 Apr 24.

Advancing clinical research globally: Cervical cancer research network from Mexico.

Autor: Ager BJ; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Gallardo-Rincón D; Ovarian and Endometrium Program, Instituto Nacional de Cancerología, México City, Mexico., de León DC; Sub-Direction of Clinical Research, Instituto Nacional de Cancerología, México City, Mexico., Chávez-Blanco A; Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México (GICOM), México City, Mexico., Chuang L; Department of Obstetrics, Gynecology, and Reproductive Science, Mount Sinai, New York City, NY, USA., Dueñas-González A; Biomedical Research Unit in Cancer, Instituto de Investigaciones Biomédicas UNAM/Instituto Nacional de Cancerología, Mexico City, Mexico., Gómez-García E; Centro Oncológico Estatal ISSEMyM, Toluca de Lerdo, Mexico., Jerez R; Centro Oncológico Hondureño, Honduras., Jhingran A; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., McCormack M; University College London Hospitals, London, United Kingdom., Mileshkin L; Division of Hematology and Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Pérez-Plasencia C; Genomics Laboratory, Instituto Nacional de Cancerología, México City, Mexico., Plante M; Department of Gynecologic Oncology, Hotel-Dieu de Quebec, Quebec, Canada., Poveda A; Department of Gynecologic Oncology, Instituto Valenciano de Oncologia, Valencia, Spain., Gaffney DK; Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Publikováno v: Gynecologic oncology reports [Gynecol Oncol Rep] 2018 Jun 12; Vol. 25, pp. 90-93. Date of Electronic Publication: 2018 Jun 12 (Print Publication: 2018).